DCIS, known as stage 0 breast cancer, affect the cells lining the milk ducts but has not spread outside the breast.

The Internet of Things (IoT) is transforming the healthcare industry by enabling remote health monitoring and improving ...

As the world gradually enters an era of aging populations, the demand for healthcare resources is rapidly increasing. Coupled ...

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, ...

Some early breast cancer patients can safely avoid certain surgeries. That's according to two studies published Thursday that ...

Dr. John Smith, a leading expert on medical IoT, says “Remote health monitoring through the IoT is a game-changer. It gives doctors an unprecedented level of insight into their patients’ health.” In a ...

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...

Research presented at the San Antonio Breast Cancer Symposium suggests women with early-stage breast cancer could safely ...

If you've ever had a doctor order a blood test for you, chances are that they ran a complete blood count, or CBC. One of the ...

By Sameet Gupte Chronic conditions like diabetes, heart disease, and respiratory disorders often necessitate constant ...

Final approval of Philips' $25 million settlement was granted last week by U.S. District Senior Judge Joy Flowers Conti of ...

Rx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical ...